Credit Suisse (SIX:CSGN) analyst Erin Wright maintained a Buy rating on DENTSPLY SIRONA (NASDAQ:XRAY) Inc on Tuesday, setting a price target of $53, which is approximately 18.12% above the present share price of $44.87.
Wright expects DENTSPLY SIRONA Inc to post earnings per share (EPS) of -$0.44 for the third quarter of 2020.
The current consensus among 6 TipRanks analysts is for a Moderate Buy rating of shares in DENTSPLY SIRONA, with an average price target of $50.75.
The analysts price targets range from a high of $56 to a low of $45.
In its latest earnings report, released on 06/30/2020, the company reported a quarterly revenue of $490.6 million and a net profit of -$103 million. The company's market cap is $9.8 billion.
According to TipRanks.com, Credit Suisse analyst Erin Wright is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 14.4% and a 67.86% success rate.
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in York, PA.